0001213900-20-016708.txt : 20200706 0001213900-20-016708.hdr.sgml : 20200706 20200706125716 ACCESSION NUMBER: 0001213900-20-016708 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200706 DATE AS OF CHANGE: 20200706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XYNOMIC PHARMACEUTICALS HOLDINGS, INC. CENTRAL INDEX KEY: 0001697805 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-232598 FILM NUMBER: 201012797 BUSINESS ADDRESS: STREET 1: 609-610 21ST CENTURY TOWER STREET 2: 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100016 BUSINESS PHONE: 9493506999 MAIL ADDRESS: STREET 1: 609-610 21ST CENTURY TOWER STREET 2: 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100016 FORMER COMPANY: FORMER CONFORMED NAME: Bison Capital Acquisition Corp. DATE OF NAME CHANGE: 20170621 FORMER COMPANY: FORMER CONFORMED NAME: Bison Capital Acquisition Corp DATE OF NAME CHANGE: 20170209 RW 1 ea123856-rw_xynomicpharma.htm REGISTRATION WITHDRAWAL REQUEST

Xynomic Pharmaceuticals Holdings, Inc.

Suite 3306, K. Wah Centre

1010 Middle Huaihai Road
Shanghai, China

 

July 6, 2020

 

VIA EDGAR

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Re: Xynomic Pharmaceuticals Holdings, Inc. (the “Company”)
  Registration Statement on Form S-1, File No. 333-232598
  Request for Withdrawal

 

Ladies and Gentlemen:

 

The Company hereby applies for withdrawal of the Company’s Registration Statement (File No. 333-232598) on Form S-1 filed with the Securities and Exchange Commission (the “Commission”) initially filed on July 11, 2019 (together with its amendment filed thereafter, the “Registration Statement”), together with all exhibits thereto. Pursuant to Rule 477 of the Securities Act of 1933, as amended (the “Act”), the Company is withdrawing the Registration Statement, which has not been declared effective, because the Company has determined not to proceed with sale of the securities under the Registration Statement. Since the Registration Statement was not declared effective by the Commission, no shares were sold in connection with the offering described in the Registration Statement.

 

If you have any questions regarding the foregoing application for withdrawal, please do not hesitate to contact me at +86-15821996861.

 

 

Sincerely,

 

Xynomic Pharmaceuticals Holdings, Inc.

 

By: /s/ Yinglin Mark Xu
  Yinglin Mark Xu
 

Chairman of the Board,

Chief Executive Officer, and President